Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

AngioDynamics, Inc. ANGO

Healthcare  —  Medical Instruments & Supplies
15.49 0.21 1.37% as of 25 Sep
Market cap
$631.6M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

AngioDynamics, Inc. (ANGO) Business Profile

Updated before January 2025

Company Overview

AngioDynamics, Inc. (NASDAQ: ANGO) is a leading medical technology company specializing in the development, manufacturing, and commercialization of innovative, minimally invasive medical devices. Founded in 1988 and headquartered in Latham, New York, AngioDynamics has grown into a global organization with a strong presence in the healthcare industry. The company focuses on providing solutions that improve patient outcomes and address unmet medical needs in the areas of oncology, vascular access, and peripheral vascular disease.

Key leadership at AngioDynamics includes Jim Clemmer, who serves as the President and Chief Executive Officer. Under his leadership, the company has pursued strategic growth initiatives, including acquisitions and product innovations, to strengthen its position in the medical device market. AngioDynamics operates with a commitment to improving the quality of care for patients while delivering value to its stakeholders.

Core Business Segments

AngioDynamics operates across three primary business segments, each offering a range of products and services designed to address specific medical needs:

1. Oncology

AngioDynamics provides advanced solutions for the treatment of cancer, focusing on minimally invasive therapies. Key products in this segment include:

  • NanoKnife System: A groundbreaking technology that uses irreversible electroporation (IRE) to treat soft tissue tumors. It is particularly effective for patients with inoperable or difficult-to-treat cancers.
  • Solero Microwave Tissue Ablation System: A device designed for precise and efficient tumor ablation, offering a minimally invasive alternative to traditional surgical procedures.

2. Vascular Access

This segment focuses on devices that facilitate safe and efficient vascular access for patients requiring long-term intravenous therapy. Key products include:

  • BioFlo PICCs and Ports: Catheters and ports designed to reduce the risk of complications such as thrombosis and infection.
  • Smart Port Technology: Implantable ports that enhance patient comfort and ease of use for healthcare providers.

3. Peripheral Vascular

AngioDynamics offers a range of products aimed at treating peripheral vascular diseases, including deep vein thrombosis (DVT) and peripheral artery disease (PAD). Key products include:

  • AngioVac System: A device used for the removal of thrombi and emboli from the venous system.
  • Auryon Atherectomy System: A laser-based technology for the treatment of PAD, providing precision and safety during procedures.

Business Model

AngioDynamics operates on a business model that integrates product innovation, clinical support, and customer education to drive revenue growth. The company generates revenue primarily through the sale of its medical devices to hospitals, clinics, and healthcare providers. Additionally, AngioDynamics invests in research and development (R&D) to create cutting-edge technologies that address evolving medical needs.

The company also emphasizes strong customer relationships by providing training and support to healthcare professionals. This approach ensures the effective use of its products and fosters long-term partnerships with its clients. AngioDynamics’ global distribution network further enhances its ability to reach diverse markets and expand its customer base.

Strategic Direction

AngioDynamics is focused on achieving sustainable growth through innovation, strategic acquisitions, and market expansion. Key elements of its strategic direction include:

  • Product Innovation: The company continues to invest in R&D to develop new technologies and improve existing products. This includes expanding the applications of the NanoKnife System and exploring new therapeutic areas.
  • Global Expansion: AngioDynamics aims to increase its presence in international markets by leveraging its distribution network and forming strategic partnerships.
  • Sustainability Goals: The company is committed to reducing its environmental footprint and promoting sustainable practices across its operations.
  • Portfolio Diversification: AngioDynamics seeks to expand its product portfolio by entering new medical segments and acquiring complementary technologies.

Competitive Landscape

AngioDynamics operates in a highly competitive medical device industry, facing competition from both large multinational corporations and smaller specialized companies. Key competitors include:

  • Medtronic: A global leader in medical technology with a broad portfolio of products.
  • Boston Scientific: Known for its innovative solutions in interventional medicine.
  • Teleflex: A competitor in the vascular access and surgical device markets.
  • Penumbra, Inc.: Specializes in minimally invasive therapies for vascular and neurovascular conditions.

Despite the competitive landscape, AngioDynamics differentiates itself through its focus on niche markets and innovative technologies.

Risk Factors

AngioDynamics faces several risks that could impact its business operations and financial performance. Key risk factors include:

  • Market Dependence: The company relies heavily on the success of its core products, such as the NanoKnife System. Any decline in demand or regulatory challenges could affect revenue.
  • Supply Chain Disruptions: Global supply chain issues, including shortages of raw materials and transportation delays, could impact production and delivery timelines.
  • Regulatory Compliance: The medical device industry is subject to stringent regulatory requirements. Non-compliance could result in fines, product recalls, or delays in product approvals.
  • Competition: Intense competition from larger players with greater resources could limit AngioDynamics’ market share.

Recent Developments

AngioDynamics has made significant strides in recent years, including:

  • Expansion of NanoKnife Applications: The company has been conducting clinical trials to expand the indications for the NanoKnife System, including its use in treating pancreatic cancer.
  • Acquisition of Eximo Medical: This acquisition added the Auryon Atherectomy System to AngioDynamics’ portfolio, enhancing its offerings in the peripheral vascular segment.
  • Sustainability Initiatives: AngioDynamics has implemented measures to reduce waste and energy consumption across its facilities.
  • Response to Global Events: The company has adapted to challenges posed by the COVID-19 pandemic by enhancing its digital capabilities and ensuring the continuity of its supply chain.

Investment Considerations

Investors considering AngioDynamics should weigh the following strengths and risks:

Strengths:

  • Strong focus on innovation and R&D.
  • Diversified product portfolio addressing critical medical needs.
  • Commitment to sustainability and corporate responsibility.
  • Opportunities for growth in international markets.

Risks:

  • Dependence on a few key products for revenue.
  • Exposure to regulatory and compliance risks.
  • Vulnerability to supply chain disruptions.
  • Intense competition in the medical device industry.

Conclusion

AngioDynamics, Inc. is a dynamic player in the medical device industry, offering innovative solutions that address critical healthcare challenges. With a strong focus on R&D, strategic acquisitions, and global expansion, the company is well-positioned for future growth. However, investors should carefully consider the risks associated with market dependence and regulatory compliance. Overall, AngioDynamics remains a compelling choice for those seeking exposure to the growing medical technology sector.